Allergen Immunotherapy, Allergy, Asthma, Asthma in Children, Atopic Dermatitis, Rhinitis, Allergic
Conditions
Brief summary
The summary is available at --\> https://www.finnatopy.fi/summary
Detailed description
Aims and objectives ---\> https://www.finnatopy.fi/aims-and-objectives Methods ---\> https://www.finnatopy.fi/methods
Interventions
OTHERNo intervention
No intervention
Sponsors
Professor Lauri Lehtimäki
Professor Mika Mäkelä
Professor Sanna Toppila-Salmi
Professor Ilkka Junttila
Tampere University
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Inclusion criteria
Inclusion/
Exclusion criteria
---\> https://www.finnatopy.fi/methods
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Epidemiology of atopic diseases and allergic sensitization profiles in Finland | 7 years | Incidence and prevalence of asthma, specific IgE sensitization, atopic dermatitis, allergic rhinitis |
| Burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland | 7 years | Morbidity, sick leaves, medication use, costs and expences |
| Evaluate and improve the current use of diagnostic tests for atopic diseases | 7 years | Diagnostic practices, tests for allergic sensitization, lung function tests, and other laboratory measures. |
| Use and effectiveness of allergen immunotherapy in real world setting | 7 years | Real world evidence data using specific cohorts |
| Direct and indirect costs related to atopic diseases and comorbidities | 7 years | All costs, including sick leaves, absenteeism, laboratory costs, other diagnisteic tests, etc. |
Countries
Finland
Contacts
Primary ContactPéter Csonka, MD, PhD
Outcome results
None listed